Baskhanbio Pharma Inc. (XKON:354390)
South Korea
· Delayed Price · Currency is KRW 4,700.00
-160.00 (-3.29%)
At close: Dec 4, 2025
Baskhanbio Pharma Market Cap
Baskhanbio Pharma has a market cap or net worth of 32.95 billion as of December 5, 2025. Its market cap has decreased by -16.01% in one year.
Market Cap
32.95B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4,700.00
Market Cap Chart
Since July 20, 2022, Baskhanbio Pharma's market cap has decreased from 82.82B to 32.95B, a decrease of -60.21%. That is a compound annual growth rate of -23.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 32.95B | 9.44% |
| Dec 30, 2024 | 30.11B | -36.91% |
| Dec 28, 2023 | 47.72B | 16.64% |
| Dec 29, 2022 | 40.92B | -50.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 688.99T |
| SK hynix | 374.23T |
| LG Energy Solution | 95.94T |
| Samsung Biologics | 77.77T |
| Hyundai Motor Company | 58.03T |
| Doosan Enerbility | 50.72T |
| HD Hyundai Heavy Industries | 46.78T |
| KB Financial Group | 46.53T |